首页> PloS one> Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry.

Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry.

导出 OA

翻译打印收藏纠错

第一作者： Adam,Irving

第一单位： Centre for Health Economics, Monash Business School, Monash University, Melbourne, Victoria, Australia.;Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

作者： Adam,Irving ^[1] ; Dennis,Petrie ^[2] ; Anthony,Harris ^[2] ; Laura,Fanning ^[2] ; Erica M,Wood ^[3] ; Elizabeth,Moore ^[3] ; Cameron,Wellard ^[3] ; Neil,Waters ^[3] ; Kim,Huynh ^[3] ; Bradley,Augustson ^[4] ; Gordon,Cook ^[5] ; Francesca,Gay ^[6] ; Georgia,McCaughan ^[7] ; Peter,Mollee ^[8] ; Andrew,Spencer ^[9] ; Zoe K,McQuilten ^[3]

作者单位： Centre for Health Economics, Monash Business School, Monash University, Melbourne, Victoria, Australia.;Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. ^[1] Centre for Health Economics, Monash Business School, Monash University, Melbourne, Victoria, Australia. ^[2] Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. ^[3] Sir Charles Gairdner Hospital, Perth, Western Australia, Australia. ^[4] Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom. ^[5] Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Turino, Torino, Italy. ^[6] Department of Haematology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.;Medicine & Health, University of New South Wales, Sydney, New South Wales, Australia. ^[7] Princess Alexandra Hospital, The University of Queensland, Brisbane, Queensland, Australia. ^[8] Australian Centre for Blood Diseases, Alfred Health-Monash University, Melbourne, Victoria, Australia.;Department of Malignant Haematology and Stem Cell Transplantation, Alfred Health, Melbourne, Victoria, Australia. ^[9]